CV — CapsoVision, Inc
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1378325 ·
Last close
$5.83
Market Cap
$291.77M
52W High
$7.80
52W Low
$5.62
ADV30
95,638
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,792,000 | 1,329,000 | -7,093,000 | -7,033,000 | 25,945,000 | 17,933,000 | 5,725,000 |
| Dec 2025 | 3,918,000 | 1,954,000 | -7,464,000 | -7,394,000 | 18,164,000 | 10,112,000 | 4,904,000 |
| Sep 2025 | 3,538,000 | 1,914,000 | -8,019,000 | -7,921,000 | 25,661,000 | 17,787,000 | 5,219,000 |
| Jun 2025 | 3,315,000 | 1,811,000 | -4,651,000 | -4,625,000 | 9,547,000 | 1,066,000 | 148,533,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-23,944,000
Investing CF
$-98,000
Financing CF
$37,522,000
CapEx
$-98,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.54
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-162,698,000
Inventory
$3,491,000
Receivables
$1,925,000
ST Investments
—
EBIT TTM
$-27,227,000
Pretax Income TTM
$-26,949,000
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$13,891,000
EBITDA
$-29,574,000
Free Cash Flow
$-16,277,125
Enterprise Value
$283,383,488
Total Cash
$9,077,000
Total Debt
$687,000
Shares Out
50,046,913
Trailing EPS
$-1.08
Book Value
$0.26
ROE
-335.1%
ROA
-132.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,554,000 | -25,516,000 | -25,315,000 | 18,164,000 | 4,904,000 | — | -22,864,000 |
| Dec 2024 | 11,756,000 | -19,917,000 | -19,898,000 | 16,803,000 | 146,313,000 | — | -20,091,000 |
| Dec 2023 | 9,753,000 | -11,347,000 | -11,305,000 | 21,527,000 | 131,370,000 | — | -10,802,000 |
TTM Snapshot
Revenues TTM
$2,966,000
NetIncome TTM
$-5,794,000
OpCashFlow TTM
$0
Assets (Latest)
$16,803,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ANIK | Anika Therapeutics, Inc. | $285.59M | $21.34 | — |
| TMCI | TREACE MEDICAL CONCEPTS, INC. | $284.20M | $4.37 | — |
| EMBC | Embecta Corp. | $282.73M | $4.99 | — |
| RCEL | AVITA Medical, Inc. | $306.49M | $9.91 | — |
| TLSI | TriSalus Life Sciences, Inc. | $314.65M | $5.11 | — |
News headlines (Yahoo Finance, 1h cache)
CapsoVision Inc (CV) (Q2 2026) Earnings Call Highlights: AI Launch Drives Growth Amid Pricing ...
2026-08-14 05:01 · Yahoo
CapsoVision Q2 Earnings Call Highlights
2026-08-13 23:04 · Yahoo
CapsoVision Reports Second Quarter 2026 Financial Results
2026-08-13 20:05 · Yahoo
CapsoVision® Announces International Launch of AI Highlights
2026-08-03 20:30 · Yahoo
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
2026-07-02 20:05 · Yahoo
CapsoVision Q1 Earnings Call Highlights
2026-05-14 23:10 · Yahoo
CapsoVision Reports First Quarter 2026 Financial Results
2026-05-14 20:05 · Yahoo
CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026
2026-04-30 20:05 · Yahoo
CapsoVision And 2 Other Growth Stocks With Significant Insider Ownership
2026-04-24 17:35 · Yahoo
CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026
2026-07-30 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.